• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腺苷选择性减弱组胺和去甲肾上腺素引起的H2和β介导的心脏反应:揭示H1和α介导的反应。

Adenosine selectively attenuates H2- and beta-mediated cardiac responses to histamine and norepinephrine: an unmasking of H1- and alpha-mediated responses.

作者信息

Hattori Y, Levi R

出版信息

J Pharmacol Exp Ther. 1984 Nov;231(2):215-23.

PMID:6092608
Abstract

Adenosine is known to attenuate the positive inotropic and chronotropic effects of norepinephrine and histamine by reducing cyclic AMP accumulation. We assessed whether adenosine, while inhibiting the cardiac responses mediated by beta and H2 receptors, leaves unmodified the responses mediated by alpha and H1 receptors. In isolated cardiac preparations from the guinea pig, adenosine antagonized the positive inotropic effect of histamine more than that of norepinephrine. This most likely occurred because, by attenuating H2 and beta responses, adenosine unmasked the H1-negative and alpha-1-positive components of the inotropic effects of histamine and norepinephrine. Consistent with this hypothesis, the pure H2 agonist impromidine appeared to be antagonized by adenosine less than histamine, and norepinephrine less than isoproterenol. In addition, adenosine antagonized the positive inotropic effect of norepinephrine in the presence of the alpha-1 blocker prazosin, whereas it did not affect the inotropic effect of phenylephrine. In the papillary muscle depolarized by 22 mM K+, adenosine antagonized the restoration of contractile responses induced by histamine or norepinephrine. This action of adenosine was reversed by the phosphodiesterase inhibitor papaverine and by the adenylate cyclase activator forskolin, suggesting that adenosine attenuates beta and H2 responses by suppressing the cyclic AMP-dependent facilitation of Ca++ influx promoted by the two amines. Our data indicate that adenosine selectively attenuates H2 and beta but not alpha and H1 responses. Thus, when catecholamines, histamine and adenosine are released together, as in myocardial ischemia, in addition to their individual effects, negative inotropism, decreased impulse conduction velocity and coronary constriction (i.e., H1- and alpha-mediated responses) may result from the adenosine-histamine-norepinephrine interaction.

摘要

已知腺苷可通过减少环磷酸腺苷(cAMP)的积累来减弱去甲肾上腺素和组胺的正性肌力作用和变时作用。我们评估了腺苷在抑制由β受体和H2受体介导的心脏反应时,是否对由α受体和H1受体介导的反应没有影响。在豚鼠的离体心脏标本中,腺苷对组胺正性肌力作用的拮抗作用比对去甲肾上腺素的更强。这很可能是因为,通过减弱H2和β反应,腺苷揭示了组胺和去甲肾上腺素正性肌力作用中的H1负性和α-1正性成分。与该假设一致,纯H2激动剂英普咪定似乎比组胺受腺苷的拮抗作用小,而去甲肾上腺素比异丙肾上腺素受腺苷的拮抗作用小。此外,在存在α-1阻滞剂哌唑嗪的情况下,腺苷拮抗去甲肾上腺素的正性肌力作用,而它不影响去氧肾上腺素的正性肌力作用。在由22 mM钾离子使乳头肌去极化的情况下,腺苷拮抗组胺或去甲肾上腺素诱导的收缩反应的恢复。腺苷的这一作用被磷酸二酯酶抑制剂罂粟碱和腺苷酸环化酶激活剂福斯可林逆转,提示腺苷通过抑制这两种胺促进的环磷酸腺苷依赖性钙内流增强作用来减弱β和H2反应。我们的数据表明,腺苷选择性地减弱H2和β反应,但不减弱α和H1反应。因此,当儿茶酚胺、组胺和腺苷一起释放时,如在心肌缺血时,除了它们各自的作用外,负性肌力作用、冲动传导速度降低和冠状动脉收缩(即H1和α介导的反应)可能是由腺苷-组胺-去甲肾上腺素相互作用导致的。

相似文献

1
Adenosine selectively attenuates H2- and beta-mediated cardiac responses to histamine and norepinephrine: an unmasking of H1- and alpha-mediated responses.腺苷选择性减弱组胺和去甲肾上腺素引起的H2和β介导的心脏反应:揭示H1和α介导的反应。
J Pharmacol Exp Ther. 1984 Nov;231(2):215-23.
2
Cardiac histamine receptors.心脏组胺受体
Adv Myocardiol. 1980;1:209-16.
3
Inotropic effects of histamine in human myocardium: differentiation between positive and negative components.
J Cardiovasc Pharmacol. 1984 Nov-Dec;6(6):1210-5.
4
Adenosine promotes histamine H1-mediated negative chronotropic and inotropic effects on human atrial myocardium.
J Pharmacol Exp Ther. 1988 Dec;247(3):844-9.
5
Adenosine antagonizes the histamine-induced stimulation of human atrial myocardium: protection by H1-receptor blockade.腺苷可拮抗组胺对人心房肌的刺激作用:通过H1受体阻断实现保护。
Prog Clin Biol Res. 1987;230:345-60.
6
Histamine-induced negative inotropism: mediation by H1-receptors.组胺诱导的负性肌力作用:由H1受体介导。
J Pharmacol Exp Ther. 1978 Aug;206(2):274-80.
7
Inotropic, electrophysiological and biochemical responses to histamine in rabbit papillary muscles: evidence for coexistence of H1- and H2-receptors.组胺对兔乳头肌的变力性、电生理及生化反应:H1和H2受体共存的证据
J Pharmacol Exp Ther. 1990 Apr;253(1):250-6.
8
Histamine modulates contraction and cyclic nucleotides in cultured rat mesangial cells. Differential effects mediated by histamine H1 and H2 receptors.组胺调节培养的大鼠系膜细胞的收缩和环核苷酸。由组胺H1和H2受体介导的不同效应。
J Clin Invest. 1985 May;75(5):1679-89. doi: 10.1172/JCI111876.
9
Pharmacological analysis of the cardiac actions of xamoterol, a beta adrenoceptor antagonist with partial agonistic activity, in guinea pig heart: evidence for involvement of adenylate cyclase system in its cardiac stimulant actions.对具有部分激动活性的β肾上腺素能受体拮抗剂扎莫特罗在豚鼠心脏中的心脏作用进行药理学分析:腺苷酸环化酶系统参与其心脏兴奋作用的证据。
J Pharmacol Exp Ther. 1987 Sep;242(3):1077-85.
10
Differential effects of histamine mediated by histamine H1- and H2-receptors on contractility, spontaneous rate and cyclic nucleotides in the rabbit heart.组胺H1和H2受体介导的组胺对兔心脏收缩性、自发频率和环核苷酸的不同作用。
Eur J Pharmacol. 1988 Aug 24;153(2-3):221-9. doi: 10.1016/0014-2999(88)90609-7.

引用本文的文献

1
Role of nucleoside transport and purine release in a rabbit model of myocardial stunning.核苷转运和嘌呤释放在兔心肌顿抑模型中的作用
Mol Cell Biochem. 1998 Mar;180(1-2):145-51.
2
Effects of Ca2+ channel antagonists and ryanodine on H1-receptor mediated electromechanical response to histamine in guinea-pig left atria.钙离子通道拮抗剂和ryanodine对豚鼠左心房中H1受体介导的组胺机电反应的影响。
Naunyn Schmiedebergs Arch Pharmacol. 1988 Mar;337(3):323-30. doi: 10.1007/BF00168846.
3
[Alpha-adrenoceptors in the myocardium: incidence and functional significance].
[心肌中的α-肾上腺素能受体:发生率及功能意义]
Klin Wochenschr. 1985 Nov 4;63(21):1087-97. doi: 10.1007/BF02291089.
4
Electrophysiological effects of adenosine and adenosine triphosphate on sheep Purkinje fibres under normal and simulated ischaemic conditions.腺苷和三磷酸腺苷在正常及模拟缺血条件下对绵羊浦肯野纤维的电生理效应。
Br J Pharmacol. 1989 May;97(1):240-6. doi: 10.1111/j.1476-5381.1989.tb11947.x.